InSite cancels acquisition by QLT, bought by Sun Pharma instead
Executive Summary
Three months after it signed a deal to be bought by QLT Inc., publicly traded ophthalmology firm InSite Vision Inc. decided instead on a $46mm cash acquisition by Indian drug company Sun Pharmaceutical Industries Ltd.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Topical Delivery
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice